Compare · BSX vs MMED
BSX vs MMED
Side-by-side comparison of Boston Scientific Corporation (BSX) and MiniMed Group Inc. (MMED): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BSX and MMED operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- BSX is the larger of the two at $71.03B, about 12.7x MMED ($5.60B).
- BSX has been more active in the news (10 items in the past 4 weeks vs 8 for MMED).
- BSX has more recent analyst coverage (25 ratings vs 13 for MMED).
- Company
- Boston Scientific Corporation
- MiniMed Group Inc.
- Price
- $49.01-2.72%
- $19.90-2.81%
- Market cap
- $71.03B
- $5.60B
- 1M return
- -
- +18.45%
- 1Y return
- -
- +8.98%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2026
- News (4w)
- 10
- 8
- Recent ratings
- 25
- 13
Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Latest BSX
- SEC Form 4 filed by SVP, Global Controller and CAO Woodworth Emily
- SEC Form 4 filed by EVP and CFO Monson Jonathan
- Boston Scientific announces participation in Wells Fargo 21st Annual Healthcare Conference and conference call discussing third quarter 2026 results
- Director Habiger David C bought $99,937 worth of shares (2,100 units at $47.59), increasing direct ownership by 14% to 17,160 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Boston Scientific Corporation
- Director Habiger David C bought $56,887 worth of shares (1,182 units at $48.13), increasing direct ownership by 9% to 15,060 units (SEC Form 4)
- Chairman, President & CEO Mahoney Michael F bought $9,001,408 worth of shares (186,240 units at $48.33), increasing direct ownership by 13% to 1,590,024 units (SEC Form 4)
- SEC Form 4 filed by EVP & Group Pres, Cardiology Fitzgerald Joseph Michael
- Director Ludwig Edward J bought $227,400 worth of shares (5,000 units at $45.48), increasing direct ownership by 20% to 30,359 units (SEC Form 4)
- SEC Form 10-Q filed by Boston Scientific Corporation
Latest MMED
- MiniMed to Participate in Upcoming Investor Conferences
- SEC Form DEFA14A filed by MiniMed Group Inc.
- SEC Form DEF 14A filed by MiniMed Group Inc.
- MiniMed's Smallest App-Controlled Insulin Pump Now Shipping with the World's Smallest Sensor
- MiniMed Group Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SVP, Gen. Counsel, Corp. Sec. Wills Courtney Nelson covered exercise/tax liability with 1,762 shares, decreasing direct ownership by 1% to 136,384 units (SEC Form 4) (withholding tax)
- EVP Ch. Prod. & Tech Officer Dianaty Ali covered exercise/tax liability with 8,012 shares, decreasing direct ownership by 2% to 315,158 units (SEC Form 4) (withholding tax)
- Chief Executive Officer Dallara Que covered exercise/tax liability with 31,350 shares, decreasing direct ownership by 3% to 884,749 units (SEC Form 4) (for tax liability)
- EVP, Chief Financial Officer Spooner Chad covered exercise/tax liability with 23,301 shares, decreasing direct ownership by 6% to 362,707 units (SEC Form 4) (withholding obligation)
- SVP, Chief HR Officer Chandrasena Gillian covered exercise/tax liability with 2,099 shares, decreasing direct ownership by 1% to 172,745 units (SEC Form 4) to cover withholding tax